Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate Read more
Horizon Therapeutics plc Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline Biologics Read more
Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies Read more
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia Read more
Novartis receives FDA Breakthrough Therapy designation for investigational 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer (mCRPC) Read more
Clinical advances of RNAi therapy discussed at Oligonucleotide Therapeutics and Delivery Conference 2021 Read more
Workshop on Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements Read more
Lumen Bioscience and Novo Nordisk Enter into Research Collaboration to Explore Novel Strategies to Deliver Oral Biologics for Cardiometabolic Disease Read more
United Therapeutics Announces FDA Acceptance of Tyvaso DPI New Drug Application For Priority Review Read more